Fundz

Kyverna Appoints Dr. Naji Gehchan as Chief Medical and Development Officer

PUBLIC · KYTXJan 21, 2025

Position

Chief Development Officer

Company

Kyverna Therapeutics

Naji Gehchan
ngehchan@kyvernatx.com
EmeryvilleBiotechnologyHealth CareScience And Engineering

Description

Kyverna Therapeutics, Inc. announced the appointment of Dr. Naji Gehchan, who brings 20 years of U.S

Quick answer

Kyverna Appoints Dr. Naji Gehchan as Chief Medical and Development Officer (January 21, 2025). Kyverna Therapeutics is based in Emeryville, California, United States.

Who is the new Chief Development Officer at Kyverna Therapeutics?
Kyverna Therapeutics named Naji Gehchan Chief Development Officer, announced January 21, 2025.
What did Kyverna Therapeutics announce on January 21, 2025?
Kyverna Therapeutics, Inc. announced the appointment of Dr. Naji Gehchan, who brings 20 years of U.S
What does Kyverna Therapeutics do?
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
Where is Kyverna Therapeutics based?
Kyverna Therapeutics is based in Emeryville, California, United States.
Which similar companies made leadership changes around the same time?
Emmes (January 16, 2025), Cardurion Pharmaceuticals (January 8, 2025), Septerna (January 6, 2025) and Envisagenics (February 13, 2025) also announced leadership changes within 45 days of Kyverna Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Kyverna Therapeutics, and when

A new leader at Kyverna Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Kyverna Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kyverna Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kyverna Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kyverna Therapeutics

Location

Emeryville, California, United States

About

Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kyverna Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Karen
Likely contact at this company
••••••••@••••••••

See Karen's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kyverna Therapeutics's next move

Learn about Strategic plan

Kyverna Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.